Mochi Health Semaglutide Review 2026: Pricing, Results & Trimi Comparison
Mochi Health semaglutide is a popular compounded GLP-1 program combining a $79/month membership with $99/month injectable medication — totaling $178/month. This review covers what you actually get, how the titration works, sublingual vs injectable options, and why Trimi delivers equivalent outcomes at $79/month less per month.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting semaglutide or any prescription weight loss medication. Trimi is a competing provider; information about Mochi Health is presented based on publicly available data and should be verified directly with Mochi Health.
More on GLP-1 Provider Comparisons
Best Compounded GLP-1 Providers 2026
Ranked comparison of the top compounded semaglutide and tirzepatide providers.
Calibrate vs Trimi
How Calibrate's premium program stacks up against Trimi's $99/month plan.
Best Online Weight Loss Clinics 2026
Full breakdown of the top telehealth weight loss platforms.
Buy Semaglutide Online
How to access compounded semaglutide legally and safely online.
What is Mochi Health semaglutide?
Mochi Health semaglutide is a compounded semaglutide injectable program offered through the Mochi Health telehealth platform at $99/month for medication plus a $79/month membership fee, totaling $178/month. The program ships from 503A-registered compounding pharmacies and includes optional sublingual drop formulations as an alternative to weekly injections.
What Is Mochi Health's Semaglutide Program?
Mochi Health is a telehealth weight management platform that prescribes and ships compounded semaglutide directly to patients across the United States. The program operates on a two-component pricing structure: a $79/month platform membership fee, which covers provider access and ongoing clinical support, plus a separate $99/month charge for the compounded semaglutide injectable itself. This brings the total monthly cost to $178 — or $2,136 annually.
Semaglutide, the active ingredient in brand-name Ozempic and Wegovy, is a GLP-1 receptor agonist that works by mimicking glucagon-like peptide-1 — a hormone that regulates appetite, slows gastric emptying, and reduces caloric intake. In the landmark STEP 1 trial, patients using injectable semaglutide 2.4 mg weekly achieved an average body weight reduction of 14.9% over 68 weeks (Wilding et al., 2021, NEJM). This is the clinical foundation that all compounded semaglutide programs, including Mochi Health's, are built upon.
Mochi Health's compounded semaglutide is prepared by 503A compounding pharmacies — facilities that compound medications for individual patients under a licensed prescriber's order. This is distinct from 503B outsourcing facilities, which produce larger batch supplies. Understanding this distinction matters because it affects regulatory oversight, batch testing standards, and ultimately product consistency. Patients evaluating any compounded GLP-1 provider should confirm their pharmacy's 503A registration and state licensure.
In addition to injectable semaglutide, Mochi Health offers sublingual semaglutide drops — a liquid formulation absorbed under the tongue — as an alternative for patients who prefer to avoid needles. This is a notable differentiator in the compounded GLP-1 market. However, the clinical evidence for sublingual semaglutide absorption is considerably thinner than for the subcutaneous injectable route used in all major clinical trials.
Mochi Health Semaglutide Program: Full Details
| Program Detail | Mochi Health |
|---|---|
| Medication | Compounded semaglutide injectable |
| Membership fee | $79/month |
| Medication cost | $99/month (injectable) |
| Total monthly cost | $178/month |
| Annual cost | ~$2,136/year |
| Starting dose | 0.25 mg/week |
| Delivery format | Injectable + sublingual drops available |
| Pharmacy type | 503A compounding pharmacies |
| Shipping | Shipped directly to patient |
| Commitment | Month-to-month |
Mochi Health Semaglutide Dosing & Titration Schedule
Mochi Health follows the standard semaglutide titration protocol, beginning at a low dose to minimize gastrointestinal side effects and progressively increasing to the therapeutic maintenance dose. This mirrors the titration schedule used in the STEP clinical trials. Here is the typical progression:
Titration is individualized. Some patients remain at 1.0 mg or 1.7 mg long-term if they achieve their weight goals or experience side effects at higher doses. Dose advancement is always guided by your prescribing provider. Never self-adjust semaglutide dosing. See our full guide on GLP-1 dosing and titration.
Injectable vs Sublingual Semaglutide: What Mochi Offers
One of Mochi Health's differentiating features is offering sublingual semaglutide drops alongside the standard injectable form. Understanding the tradeoffs between these two delivery methods is critical for making an informed treatment decision.
Injectable Semaglutide
- Subcutaneous injection — same route as all STEP trial data
- Consistent, predictable bioavailability
- Once-weekly dosing — minimal daily burden
- Strongest evidence base for 14.9% average weight loss
- Requires needle — may deter needle-averse patients
Sublingual Drops
- No needles — accessible for injection-averse patients
- Daily or multi-daily dosing schedule
- Limited published clinical trial evidence for this route
- Bioavailability may be lower and less consistent than injectable
- Daily compliance burden higher than weekly injection
The clinical evidence behind semaglutide is built entirely on subcutaneous injectable formulations. The STEP program, STEP 1 through STEP 5, all used weekly subcutaneous injections. Patients considering sublingual drops should have an informed discussion with their provider about the evidence differences. Injectable compounded semaglutide, available at both Mochi Health and Trimi, is the format most closely aligned with the clinical trial data.
Mochi Health vs Trimi: Full Cost Comparison
Cost is the most significant practical difference between Mochi Health and Trimi. Both platforms offer compounded semaglutide injectable with licensed provider oversight — but their pricing models differ substantially. Mochi charges for membership and medication separately; Trimi bundles everything into one flat monthly rate.
| Cost Factor | Mochi Health | Trimi |
|---|---|---|
| Membership / platform fee | $79/month | Included |
| Compounded semaglutide injectable | $99/month | Included in $99/mo total |
| Provider consultations | Included (in $79 fee) | Included |
| Titration support | Included | Included |
| Sublingual option | Available | Injectable standard |
| Commitment | Month-to-month | Month-to-month |
| Total monthly cost | $178/month | $99/month |
| Total annual cost | ~$2,136/year | ~$1,188/year |
| Annual savings with Trimi | — | $948/year |
Over a typical 12-month semaglutide treatment course, patients choosing Trimi over Mochi Health save $948. Over 24 months — reflecting common long-term GLP-1 treatment patterns — that savings reaches nearly $1,900. The medication and clinical management are comparable; the difference is entirely in the cost structure. Learn more about affordable compounded GLP-1 options in 2025–2026.
Mochi Health Semaglutide: Delivery & Shipping
Mochi Health ships compounded semaglutide directly to patients from 503A compounding pharmacies. Like most compounded GLP-1 providers, medication arrives refrigerated or at controlled room temperature depending on formulation. Standard shipping timelines for compounded semaglutide programs typically range from 3 to 7 business days after prescription verification.
Medication ships from licensed 503A compounding pharmacies
Shipments are temperature-controlled to maintain medication integrity
Prescription verification typically completed within 1–3 business days
Standard delivery 3–7 business days after pharmacy dispatch
Refills can typically be requested through the Mochi Health patient portal
Sublingual drops and injectables may ship from different pharmacy facilities
Before starting any compounded semaglutide program, confirm that the shipping pharmacy holds current 503A registration in your state. State pharmacy board compliance is distinct from FDA 503A registration — both matter for patient safety.
Expected Results Timeline on Mochi Health Semaglutide
Compounded semaglutide from Mochi Health contains the same active molecule as Ozempic and Wegovy. Results timelines are therefore grounded in the published STEP trial data, which used identical dosing protocols. Individual results vary based on adherence, diet, activity, and metabolic factors.
Most patients begin noticing reduced hunger and smaller portion sizes. Some experience early nausea as the GI tract adjusts. Average weight loss in the first month is typically 2–4 lbs.
Appetite suppression becomes more pronounced. Weekly weight loss of 0.5–1.5 lbs is common. Patients often report reduced cravings for high-calorie foods.
Cumulative losses of 8–15 lbs are typical for compliant patients at this stage. The STEP 1 trial showed approximately 9% body weight reduction at 20 weeks.
The STEP 1 trial reported 14.9% average body weight loss at 68 weeks (Wilding et al., 2021). For a 200 lb patient, this represents approximately 30 lbs of weight reduction.
Continued semaglutide use maintains weight loss. Discontinuation without lifestyle modifications leads to weight regain in most patients — a pattern observed consistently in STEP extension trials.
For a deeper look at what to expect on your GLP-1 journey, read our guide on GLP-1 weight loss timelines and realistic expectations.
Provider Support: Mochi Health vs Trimi
Both Mochi Health and Trimi offer telehealth-based provider support. The structure and emphasis differ, but both platforms provide the clinical oversight required for responsible compounded semaglutide prescribing.
| Support Feature | Mochi Health | Trimi |
|---|---|---|
| Initial medical consultation | Included (in $79 membership) | Included in $99/mo |
| Ongoing titration oversight | Included | Included |
| Provider messaging | Available via portal | Available |
| Nutrition / lifestyle coaching | Available (varies by plan) | Not included |
| Side-effect management | Included | Included |
| Prescription refill process | Via patient portal | Via patient portal |
For most patients, the clinical support provided by both platforms is functionally equivalent for the purpose of safe compounded semaglutide management. Mochi's $79 membership fee primarily covers platform infrastructure and care coordination that Trimi bundles into its single $99/month price. Neither platform offers the intensive behavioral coaching of premium programs like Calibrate — but for the majority of patients, medication and standard clinical oversight produce excellent outcomes. See our best GLP-1 provider comparison for 2026 for a broader landscape view.
What Mochi Health Does Well
Established telehealth platform with a dedicated weight management focus
Offers both injectable and sublingual semaglutide — rare format flexibility
Ships from 503A-registered compounding pharmacies with standard quality controls
Standard titration protocol aligned with STEP trial dosing methodology
Month-to-month pricing with no long-term contract commitment
Multi-state availability enabling broad patient access across the US
Provider messaging support for side-effect management and titration adjustments
Where Mochi Health Falls Short
Two-component pricing ($79 membership + $99 medication) totals $178/month — 80% more than Trimi's $99/month all-inclusive
Annual cost of $2,136 is $948 more than Trimi's $1,188 annual total
Sublingual drops lack the clinical evidence base of the injectable route used in STEP trials
503A compounding pharmacies face ongoing FDA regulatory scrutiny — compliance status should be verified
Split pricing model is less transparent than a true all-inclusive single monthly fee
No published comparative outcomes data versus other telehealth GLP-1 providers
Verdict: Is Mochi Health Semaglutide Worth It?
Mochi Health is a legitimate, functional compounded semaglutide program. It delivers the right molecule — semaglutide — through a standard titration protocol from licensed compounding pharmacies, with clinical oversight included. For patients who value the flexibility of sublingual drops or who are already established with the Mochi platform, the experience is reasonable.
The primary friction point is the $178/month price tag. When the same compounded semaglutide injectable — same molecule, same titration, same clinical oversight structure — is available from Trimi at $99/month all-inclusive, the math is difficult to ignore. The $79/month Mochi membership fee funds platform infrastructure and care coordination, but these services are included in Trimi's single flat rate. Patients who choose Mochi pay $948 more per year without a clear clinical benefit justifying the difference.
For needle-averse patients who genuinely need a sublingual option, Mochi's format flexibility offers something Trimi does not. But even in this case, patients should weigh the reduced evidence base of sublingual semaglutide against the advantages of the injectable route before committing. If injections are manageable, the injectable at Trimi costs 44% less per month with equivalent clinical support.
Ultimately, both programs use the same FDA-regulated active ingredient. The GLP-1 receptor agonism that drives weight loss is identical. The STEP 1 trial result of 14.9% average body weight loss is the ceiling that all compounded semaglutide programs — Mochi Health and Trimi included — aim toward. The platform you choose determines what you pay to get there, not what your body is capable of achieving. For a broader comparison of providers in this space, see our best compounded GLP-1 providers guide.
Frequently Asked Questions
What is Mochi Health semaglutide?
Mochi Health's semaglutide program provides compounded semaglutide injectable shipped from FDA-registered 503A compounding pharmacies. The program includes a $79/month membership fee plus $99/month for the compounded semaglutide medication, bringing the total to $178/month. Mochi also offers sublingual semaglutide drops as a needle-free alternative. Patients start at the standard 0.25 mg dose and titrate upward under provider supervision.
How much does Mochi Health semaglutide cost in 2026?
Mochi Health charges $79/month for membership plus $99/month for compounded semaglutide injectable, totaling $178/month or approximately $2,136 per year. Sublingual drop pricing may differ. By comparison, Trimi's all-inclusive compounded semaglutide program is $99/month ($1,188/year) with no separate membership fee — a savings of $948 annually over Mochi Health.
Is Mochi Health semaglutide compounded or brand-name?
Mochi Health uses compounded semaglutide, not the brand-name Ozempic or Wegovy. It is shipped from 503A compounding pharmacies, which prepare medications for individual patients under a licensed prescriber's order. Compounded semaglutide contains the same active ingredient as the brand-name product but is not FDA-approved in the same way. The FDA cleared the shortage-period compounding window that many telehealth providers relied on; always verify your provider's current pharmacy compliance status.
What is the Mochi Health semaglutide titration schedule?
Mochi Health follows standard semaglutide titration, beginning at 0.25 mg weekly for the first four weeks. Doses typically advance to 0.5 mg, then 1 mg, and up to 2.4 mg depending on tolerance and weight loss response. Dose increases are made in consultation with Mochi's clinical team. This titration mirrors the STEP 1 trial protocol used to achieve 14.9% average body weight loss (Wilding et al., 2021, NEJM).
Does Mochi Health offer sublingual semaglutide?
Yes. Mochi Health offers sublingual semaglutide drops as an alternative to weekly injections. Sublingual administration allows the drug to absorb through the tissue under the tongue. However, sublingual semaglutide does not have the same clinical evidence base as subcutaneous injectable semaglutide — the STEP trials that demonstrated 14.9% weight loss used injectable formulations. Injectable delivery produces more predictable and consistent bioavailability.
How does Mochi Health compare to Trimi for semaglutide?
Both Mochi Health and Trimi provide compounded semaglutide with provider oversight. The key differences are cost and simplicity. Mochi charges $178/month ($79 membership + $99 medication), while Trimi charges $99/month all-inclusive — a $948 annual difference. Trimi uses a straightforward single monthly price with no separate membership fee, whereas Mochi's two-component pricing can feel less transparent. Provider support, titration protocols, and injectable compounded semaglutide quality are comparable between the two platforms.
Is Mochi Health's semaglutide safe and legitimate?
Mochi Health is a legitimate telehealth platform that employs licensed providers and ships from 503A-registered compounding pharmacies. Like all compounded GLP-1 providers, patients should verify current FDA compliance status and pharmacy licensure. As of 2026, the FDA has issued guidance on compounded semaglutide following the shortage resolution. Any provider shipping compounded semaglutide should be transparent about their pharmacy's regulatory standing. Consult a licensed healthcare provider before starting any semaglutide program.
Sources & References
- Wilding JPH, et al. "Once-weekly semaglutide in adults with overweight or obesity." NEJM. 2021;384(11):989–1002. (STEP 1 trial — PubMed)
- Rubino DM, et al. "Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity." JAMA. 2021;325(14):1414–1425. (STEP 4 — PubMed)
- FDA. "Compounding and the FDA: Questions and Answers." FDA.gov. Accessed April 2026.
- Davies M, et al. "Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2)." Lancet. 2021;397(10278):971–984. (STEP 2 — PubMed)
- Mochi Health. Official program pricing and information. Accessed April 2026. (Verify current pricing directly at mochihealth.com.)
- American Board of Obesity Medicine (ABOM). "Standards of Practice in Obesity Medicine." 2025.
- US Pharmacopeia (USP). "Standards for Compounding Pharmacies — 503A Facilities." USP General Chapter <797>. 2023 revision.
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Semaglutide is a prescription medication and must be obtained through a licensed healthcare provider. Individual results vary. Trimi is a competing provider to Mochi Health; while we have made every effort to present accurate information, readers should verify all pricing and program details directly with Mochi Health. Always consult a qualified physician or other licensed healthcare professional before starting any weight loss medication.